valrubicin 40 MG/ML Intravesical Solution
- RxCUI
- 313567
- RxNorm name
- valrubicin 40 MG/ML Intravesical Solution
- Display name
- valrubicin 40 MG/ML Intravesical Solution
- Full name
- valrubicin 40 MG/ML Intravesical Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valstar | VALRUBICIN | Endo USA, Inc. | e96f30a0-6662-11de-8f80-0002a5d5c51b | 2024-10-31 | Warnings, Adverse reactions | 313567 |
| Valrubicin Intravesical Solution | VALRUBICIN INTRAVESICAL SOLUTION | Hikma Pharmaceuticals USA Inc. | 8739ae02-e4c5-0fa2-e053-2a91aa0a1b74 | 2022-06-30 | Warnings, Adverse reactions | 313567 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e96f30a0-6662-11de-8f80-0002a5d5c51b | valrubicin 200 MG per 5 ML Intravesical Solution | SY | 38 | These highlights do not include all the information needed to use VALSTAR safely and effectively. See full prescribing information for VALSTAR. VALSTAR ® (valrubicin) solution, for intravesical use Initial U.S. Approval: 1981 | 20241031 |
| e96f30a0-6662-11de-8f80-0002a5d5c51b | valrubicin 200 MG in 5 mL (40 MG/mL) Intravesical Solution | PSN | 38 | These highlights do not include all the information needed to use VALSTAR safely and effectively. See full prescribing information for VALSTAR. VALSTAR ® (valrubicin) solution, for intravesical use Initial U.S. Approval: 1981 | 20241031 |
| e96f30a0-6662-11de-8f80-0002a5d5c51b | valrubicin 40 MG/ML Intravesical Solution | SCD | 38 | These highlights do not include all the information needed to use VALSTAR safely and effectively. See full prescribing information for VALSTAR. VALSTAR ® (valrubicin) solution, for intravesical use Initial U.S. Approval: 1981 | 20241031 |
| 8739ae02-e4c5-0fa2-e053-2a91aa0a1b74 | valrubicin 200 MG in 5 mL (40 MG/mL) Intravesical Solution | PSN | 2 | These highlights do not include all the information needed to use VALRUBICIN INTRAVESICAL SOLUTION safely and effectively. See full prescribing information for VALRUBICIN INTRAVESICAL SOLUTION. VALRUBICIN intravesical solution, for intravesical use Initial U.S. Approval: 1981 | 20220630 |
| 8739ae02-e4c5-0fa2-e053-2a91aa0a1b74 | valrubicin 40 MG/ML Intravesical Solution | SCD | 2 | These highlights do not include all the information needed to use VALRUBICIN INTRAVESICAL SOLUTION safely and effectively. See full prescribing information for VALRUBICIN INTRAVESICAL SOLUTION. VALRUBICIN intravesical solution, for intravesical use Initial U.S. Approval: 1981 | 20220630 |
| 8739ae02-e4c5-0fa2-e053-2a91aa0a1b74 | valrubicin 200 MG per 5 ML Intravesical Solution | SY | 2 | These highlights do not include all the information needed to use VALRUBICIN INTRAVESICAL SOLUTION safely and effectively. See full prescribing information for VALRUBICIN INTRAVESICAL SOLUTION. VALRUBICIN intravesical solution, for intravesical use Initial U.S. Approval: 1981 | 20220630 |